Home HealthTopics Health Centers Reference Library Research
Join us on Facebook Join us on Facebook Share on Facebook
Share

Pulmonary Fibrosis

Serracor-NK

07/08/2010

Question:

Is SERRACOR-N K a viable treatment for pulmonary fibrosis and has it been tested in clinical trials. I am interested in taking it but need more info. I don`t want to take something that may cause other problems.

Answer:

Serrapeptase has not been tested in well-designed randomized controlled studies in humans and there is currently no compelling scientific evidence that it has any benefit to patients with pulmonary fibrosis. In fact, there are at least two reports of patients developing interstitial lung disease after taking serrapeptase.

There are many companies selling serrapeptase who have made claims of it working in patients with inflammation, etc., however, there is no reliable evidence that it has any effect. It is sold as a nutritional supplement and not as a drug. As such, it is not subject to regulation by the FDA.

For more information:

Go to the Pulmonary Fibrosis health topic, where you can:

Response by:

Clay B Marsh, MD Clay B Marsh, MD
Vice Dean of Medicine Administration
Professor of Molecular Virology, Immunology & Medical Genetics
Professor of Veterinary Biosciences
Associate Vice President of Health Sciences Research Administration
College of Medicine
The Ohio State University

James N Allen, Jr, MD James N Allen, Jr, MD
Clinical Professor of Pulmonary, Allergy, Critical Care & Sleep Medicine
College of Medicine
The Ohio State University